InMed Pharmaceuticals Inc. (MTRI) income statement
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
$15.29−2.21 (-12.66%)
Close on Nov 18, 2026Market cap $83.97MP/E –Yield –
InMed Pharmaceuticals Inc. financial ratios
See a number that looks wrong?